Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population
{{output}}
We performed a retrospective cohort study to evaluate risk of antidepressant discontinuation as a function of CYP2C19 and CYP2D6 phenotype. Patients who participated in an elective genomic screening and had a diagnosis of depression or anxiety with a correspon... ...
